Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143762 |
| CAS No | NA |
| Mol.F. | C17H18N2O5 |
| Mol.Wt. | 330.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143763 |
| CAS No | NA |
| Mol.F. | C19H20N2O6 |
| Mol.Wt. | 372.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143764 |
| CAS No | NA |
| Mol.F. | C17H18N2O5 |
| Mol.Wt. | 330.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143765 |
| CAS No | NA |
| Mol.F. | C10H11D5N4OS |
| Mol.Wt. | 245.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143766 |
| CAS No | 20002-23-7 |
| Mol.F. | C14H10D4N2O |
| Mol.Wt. | 230.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143767 |
| CAS No | NA |
| Mol.F. | C19H17D3N2O |
| Mol.Wt. | 295.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143768 |
| CAS No | 17829-05-9 |
| Mol.F. | C2D6N2O |
| Mol.Wt. | 80.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143769 |
| CAS No | 1346603-41-5 |
| Mol.F. | C4H6D4N2O |
| Mol.Wt. | 106.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143770 |
| CAS No | 2483824-56-0 |
| Mol.F. | 13C2D6N2O |
| Mol.Wt. | 82.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143771 |
| CAS No | 42513-20-2 |
| Mol.F. | C10H14N2O2 |
| Mol.Wt. | 194.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143772 |
| CAS No | 86451-37-8 |
| Mol.F. | C4H10N2O3 |
| Mol.Wt. | 134.1 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143773 |
| CAS No | 62783-48-6 |
| Mol.F. | C9H12N2O |
| Mol.Wt. | 164.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143774 |
| CAS No | NA |
| Mol.F. | C22H22N4O5 |
| Mol.Wt. | 422.16 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143775 |
| CAS No | NA |
| Mol.F. | C22H21N3O5 |
| Mol.Wt. | 407.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143776 |
| CAS No | 756524-88-6 |
| Mol.F. | C5H7D4N3O |
| Mol.Wt. | 133.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143777 |
| CAS No | 1184974-41-1 |
| Mol.F. | C5H8D3N3O |
| Mol.Wt. | 132.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |